Purchase of Shares via Employee Benefit Trust

Summary by AI BETAClose X

Eurocell plc announced that its Employee Benefit Trust acquired 100,000 ordinary shares at a weighted average price of 118.75 pence per share, following a previous announcement. These shares are held unallocated for future employee awards under the company's share schemes. The Trust now holds a total of 349,560 ordinary shares, representing 0.35% of the company's issued share capital.

Disclaimer*

Eurocell plc
05 August 2026
 

EUROCELL PLC

("Eurocell" or the "Company")

 

Purchase of Shares via Employee Benefit Trust

 

Further to the announcement made on 31 July 2026, Eurocell plc, the leading UK manufacturer and distributor of door and window products to the trade announces that it was notified on 3 August 2026 that Equiniti Trust (Jersey) Limited acting in its capacity as trustee of the Eurocell Employee Benefit Trust (the "Trust"), has now acquired 100,000 of the Company's ordinary shares of 1p each ("Shares") at a weighted average price of 118.75 pence per Share.

 

The Shares are held in the Trust, which is a discretionary trust for the benefit of the Group's employees. The Shares are held on an unallocated basis for use in satisfying both current and future awards under the Company's various share schemes from time to time. 

As at today, the Trust holds a total of 349,560 ordinary shares, equating to 0.35% of the Company's issued share capital.

~~~~~~~~~~~~~~~~~~~~~~~

 

Enquiries:

Vicky Williams

Group Company Secretary

Tel: 01773 842100

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Eurocell (ECEL)
UK 100

Latest directors dealings